From Dr. Laura Lubbers <[email protected]>
Subject Research Discovery: Taking Flight Awardee Makes Strides Towards Development of a Biomarker with Implications for Acquired Epilepsies
Date October 6, 2023 9:00 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
This work provides insights into changes in brain activity that may be extended to people at risk of developing epilepsy after a brain injury.

View this email in your browser ([link removed])


** CURE Epilepsy Discovery
------------------------------------------------------------
[link removed]


** Taking Flight Awardee Makes Strides Towards Development of a Biomarker with Implications for Acquired Epilepsies ([link removed])
------------------------------------------------------------

This work provides insights into changes in brain activity that may be extended to people at risk of developing epilepsy after a brain injury.

Acquired epilepsies can result from brain injury such as head trauma or a lack of oxygen (hypoxia) which can occur following a heart attack or cardiac arrest.[1] Often, there is a period of time between the initial injury and the onset of seizures referred to as the "latent" period. During this time, individuals do not experience seizure activity, but a process called epileptogenesis may be at play to change brain activity, making it more hyperexcitable and prone to seizures. This subset of individuals begins to experience spontaneous seizures and develop epilepsy. Knowledge about changes in the brain after the initial injury may provide clues about ways to prevent seizures. A biomarker is a biological factor such as a protein in the blood or brain electrical activity that can be objectively measured and can act as an indicator or even predictor of a normal or an abnormal condition. In epilepsy, a biomarker could provide information on who is at the highest risk of developing seizures
following a brain injury.

Research on biomarkers of acquired epilepsies is challenging, however, due to the inherent complexity of different types of epilepsy, the variability that exists between people at risk for epilepsy, and the challenges of monitoring people acutely after an injury that puts them at risk for epilepsy.[2] Knowing the impact that finding biomarkers for the epilepsies could have on patients and families, CURE Epilepsy funds research in this area. Dr. Edilberto Amorim ([link removed]) at the University of California, San Francisco practices at the Zuckerberg San Francisco General Hospital, and received a Taking Flight Award ([link removed]) in 2020. Taking Flight Awards fund investigators in the field of the epilepsies relatively early in their careers to enable them to develop a research focus and team independent of their mentor(s). Dr. Amorim’s research involves studying brain
activity using electroencephalography (EEG) to predict health outcomes in patients who are critically ill. The goal of his research is to develop data-driven approaches to develop personalized therapies. His work builds on previous studies that have identified several EEG patterns that may serve as biomarkers for the epilepsies.[3]
Read More ([link removed])

Today's CURE Epilepsy Discovery has the ability to help the 65 million people worldwide who are impacted by epilepsy every day.
And each one of those individuals has a story.
[link removed]

Read Cory’s Story ([link removed])

Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research.

CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization. Our tax identification number is 36-4253176.
[link removed]
[link removed] [link removed] [link removed] [link removed] [link removed] [link removed]

Copyright (C) 2023 CURE Epilepsy. All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
USA
Want to change how you receive these emails?
You can update your preferences ([link removed]) or unsubscribe ([link removed])

This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
CURE Epilepsy . 420 Wabash Ave, Ste 650 . Chicago, IL 60611 . USA
Screenshot of the email generated on import

Message Analysis